Androgen-induced miR-135a acts as a tumor suppressor through downregulating RBAK and MMP11, and mediates resistance to androgen deprivation therapy
Xuechao Wan(Shijiazhuang Yiling Pharmaceutical (China)), Yao Li(Cornell University), Zhuoran Yang(Nanjing Forestry University), Yalong Zhang(Dartmouth College), Zhe Kong(Fudan University), Wenhua Huang(State Key Laboratory of Genetic Engineering), Ao Li(Université Libre de Bruxelles), Tao Li(Health Biomed (China)), Peiqing Zhao(Central Hospital of Zibo), Honglei Pu(State Key Laboratory of Genetic Engineering), Shu Yang(Jiangnan University)
Cited by 43
Related Papers
Large recurrent microdeletions associated with schizophrenia
|Nature|2008|1.8k
Reduced default mode network functional connectivity in patients with recurrent major depressive disorder
|Proceedings of the National Academy of Sciences|2019|865
Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study
|The Lancet Psychiatry|2021|826
A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders.
|PubMed|1996|666
The MATRICS Consensus Cognitive Battery (MCCB): Co-norming and standardization in China
|Schizophrenia Research|2015|320